Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
百度集團-SW
09888
5
京東健康
06618
| (FY)2025/03/31 | (FY)2024/03/31 | (Q4)2024/03/31 | (Q3)2023/12/31 | (Q2)2023/09/30 | (Q1)2023/06/30 | (FY)2023/03/31 | (Q4)2023/03/31 | (Q3)2022/12/31 | (Q2)2022/09/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | 4.74%118億 | -9.88%112.66億 | -10.20%27.73億 | -17.04%29.12億 | -8.23%27.72億 | -2.55%28.1億 | 0.74%125.01億 | 3.10%30.87億 | 12.17%35.1億 | -3.03%30.21億 |
| 主營業務成本 | 1.19%72.59億 | -4.52%71.74億 | -10.14%17.58億 | -14.77%18.14億 | 1.84%18.05億 | 8.45%17.97億 | 5.92%75.14億 | 10.32%19.57億 | 22.29%21.28億 | -2.20%17.73億 |
| 毛利 | 10.97%45.41億 | -17.95%40.92億 | -10.31%10.14億 | -20.54%10.98億 | -22.53%9.67億 | -17.40%10.13億 | -6.17%49.87億 | -7.39%11.31億 | -0.51%13.82億 | -4.19%12.48億 |
| 營業費用 | 2.80%36.24億 | 6.06%35.26億 | 18.02%9.7億 | 8.66%8.71億 | 2.14%8.71億 | -4.04%8.14億 | 1.95%33.24億 | -0.63%8.22億 | 0.19%8.01億 | 7.24%8.53億 |
| 營業利潤 | 61.75%9.16億 | -65.93%5.67億 | -85.68%4,421.6萬 | -60.81%2.28億 | -75.77%9,574.4萬 | -47.37%1.99億 | -19.05%16.63億 | -21.58%3.09億 | -1.45%5.81億 | -22.11%3.95億 |
| 營業外利息收入與支出淨額 | 40.71%1,972.4萬 | 75.98%1,401.7萬 | 9.65%352.3萬 | 12.50%355.6萬 | 43.42%355.1萬 | 482.71%338.7萬 | 310.60%796.5萬 | 491.83%321.3萬 | 451.22%316.1萬 | 351.37%247.6萬 |
| 營業外利息收入 | 31.41%2,109.6萬 | 42.01%1,605.3萬 | 2.89%398.2萬 | 1.80%402.3萬 | 16.89%407萬 | --397.8萬 | 376,700.00%1,130.4萬 | 386,900.00%387萬 | --395.2萬 | 174,000.00%348.2萬 |
| 營業外利息支出 | -32.61%137.2萬 | -39.02%203.6萬 | -30.14%45.9萬 | -40.96%46.7萬 | -48.41%51.9萬 | -33.22%59.1萬 | -11.78%333.9萬 | -19.98%65.7萬 | -12.11%79.1萬 | 1.93%100.6萬 |
| 投資淨收益 | 92.17%-132.5萬 | -112.47%-27.9萬 | 124.90%119.4萬 | 88.77%-133.6萬 | 63.50%-90.4萬 | -435.31%-1,693.2萬 | 256.72%223.8萬 | -200.06%-479.5萬 | -1,189.8萬 | |
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | 0 | -2.05億 | ||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入(費用) | 100.43%8,000 | -36.37%-184.1萬 | -26.07%-170.2萬 | -13.9萬 | -55.17%-135萬 | -812.16%-135萬 | 0 | |||
| 減:其他特殊費用 | -100.43%-8,000 | 36.37%184.1萬 | --170.2萬 | ---- | ---- | ---- | 55.17%135萬 | ---- | ---- | ---- |
| 其他營業外收入(費用) | 154.35%1,541.6萬 | 612.34%606.1萬 | -33.77%-449.6萬 | 249.04%62萬 | 302.77%566.7萬 | 259.73%427萬 | -125.72%-118.3萬 | -753.05%-336.1萬 | -129.84%-41.6萬 | 11.76%140.7萬 |
| 稅前利潤 | 63.09%9.52億 | -59.65%5.84億 | -60.40%4,126.3萬 | -59.77%2.33億 | -73.23%1.04億 | -45.27%2.06億 | -29.50%14.46億 | -73.36%1.04億 | -1.61%5.79億 | -23.68%3.87億 |
| 所得稅 | 51.42%3.37億 | -55.10%2.23億 | -42.70%2,277.9萬 | -60.73%7,290.4萬 | -70.46%4,194.5萬 | -33.87%8,518.6萬 | -24.78%4.96億 | -64.34%3,975.1萬 | -7.95%1.86億 | -17.19%1.42億 |
| 除稅後利潤 | 70.29%6.14億 | -62.03%3.61億 | -71.32%1,848.5萬 | -59.31%1.6億 | -74.84%6,167.8萬 | -51.22%1.21億 | -31.74%9.5億 | -76.95%6,444.5萬 | 1.70%3.93億 | -26.99%2.45億 |
| 持續經營利潤 | 70.29%6.14億 | -62.03%3.61億 | -71.32%1,848.4萬 | -59.31%1.6億 | -74.84%6,167.9萬 | -51.22%1.21億 | -31.74%9.5億 | -76.95%6,444.6萬 | 1.70%3.93億 | -26.99%2.45億 |
| 歸屬于少數股東的淨利潤 | 1.55%6,339.2萬 | -18.79%6,242.5萬 | -21.79%1,610.9萬 | -32.17%1,611.3萬 | -11.20%1,271.4萬 | -3.90%1,748.9萬 | -6.55%7,686.8萬 | 0.32%2,059.8萬 | 28.44%2,375.4萬 | -17.15%1,431.7萬 |
| 歸屬於母公司的淨利潤 | 84.68%5.51億 | -65.84%2.98億 | -94.58%237.6萬 | -61.06%1.44億 | -78.79%4,896.5萬 | -54.98%1.03億 | -33.32%8.73億 | -83.08%4,384.7萬 | 0.36%3.69億 | -27.52%2.31億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | 84.68%5.51億 | -65.84%2.98億 | -94.58%237.6萬 | -61.06%1.44億 | -78.79%4,896.5萬 | -54.98%1.03億 | -33.32%8.73億 | -83.08%4,384.7萬 | 0.36%3.69億 | -27.52%2.31億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | 84.58%22.15 | -65.82%12 | -94.32%0.1 | -61.04%5.79 | -78.79%1.97 | -55.00%4.14 | -33.33%35.11 | -83.11%1.76 | 0.34%14.86 | -27.48%9.29 |
| 稀釋每股收益 | 84.58%22.15 | -65.82%12 | -94.57%0.0956 | -61.06%5.7864 | -78.79%1.9691 | -55.00%4.14 | -33.33%35.11 | -83.11%1.76 | 0.36%14.8589 | -27.52%9.283 |
| 每股派息 | -12.50%14 | 0.00%16 | 0.00%16 | 0 | 0 | 0 | 6.67%16 | 6.67%16 | 0 | 0 |
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |